ArticleRenal failure2025

Analysis of potential targets of 20S-protopanaxadiol on diabetic nephropathy based on network pharmacology, molecular docking, and experimental validation.

Chenfei Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.